Bloomage Accounts Payable vs Total Assets Analysis

688363 Stock   59.16  1.32  2.28%   
Bloomage Biotechnology financial indicator trend analysis is way more than just evaluating Bloomage Biotechnology prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bloomage Biotechnology is a good investment. Please check the relationship between Bloomage Biotechnology Accounts Payable and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Accounts Payable vs Total Assets

Accounts Payable vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bloomage Biotechnology Accounts Payable account and Total Assets. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Bloomage Biotechnology's Accounts Payable and Total Assets is 0.82. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Assets in the same time period over historical financial statements of Bloomage Biotechnology Corp, assuming nothing else is changed. The correlation between historical values of Bloomage Biotechnology's Accounts Payable and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Bloomage Biotechnology Corp are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Accounts Payable i.e., Bloomage Biotechnology's Accounts Payable and Total Assets go up and down completely randomly.

Correlation Coefficient

0.82
Relationship DirectionPositive 
Relationship StrengthStrong

Accounts Payable

An accounting item on the balance sheet that represents Bloomage Biotechnology obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bloomage Biotechnology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Assets

Total assets refers to the total amount of Bloomage Biotechnology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bloomage Biotechnology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Bloomage Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bloomage Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
As of December 1, 2024, Tax Provision is expected to decline to about 117.2 M. In addition to that, Selling General Administrative is expected to decline to about 1.5 B
 2021 2022 2023 2024 (projected)
Gross Profit3.9B4.9B4.5B2.6B
Total Revenue4.9B6.4B6.1B3.4B

Bloomage Biotechnology fundamental ratios Correlations

0.880.850.89-0.760.80.980.910.140.820.910.860.650.950.490.870.870.880.370.830.96-0.320.82-0.790.890.69
0.880.850.79-0.720.90.860.990.210.830.990.750.810.830.450.970.860.930.420.840.91-0.350.93-0.770.980.72
0.850.850.8-0.550.610.870.88-0.020.90.840.870.430.880.690.820.870.950.140.90.820.020.66-0.540.760.87
0.890.790.8-0.410.60.920.850.110.810.830.810.560.910.60.810.810.830.440.810.86-0.060.74-0.520.80.64
-0.76-0.72-0.55-0.41-0.84-0.64-0.7-0.22-0.5-0.72-0.53-0.64-0.61-0.12-0.68-0.61-0.61-0.33-0.53-0.720.64-0.720.88-0.75-0.42
0.80.90.610.6-0.840.730.860.30.640.890.580.840.680.160.830.720.760.470.660.82-0.620.89-0.890.930.53
0.980.860.870.92-0.640.730.910.090.870.890.910.640.990.580.870.890.90.240.880.97-0.150.79-0.670.860.73
0.910.990.880.85-0.70.860.910.20.90.990.820.80.890.560.970.910.960.380.910.94-0.270.93-0.740.970.74
0.140.21-0.020.11-0.220.30.090.20.190.19-0.290.39-0.060.120.110.370.00.490.230.13-0.470.35-0.240.28-0.43
0.820.830.90.81-0.50.640.870.90.190.850.830.60.850.840.820.960.940.161.00.830.070.75-0.490.80.76
0.910.990.840.83-0.720.890.890.990.190.850.790.820.870.470.980.870.930.420.860.94-0.340.95-0.780.990.72
0.860.750.870.81-0.530.580.910.82-0.290.830.790.470.950.620.80.760.90.010.820.870.090.64-0.540.720.9
0.650.810.430.56-0.640.840.640.80.390.60.820.470.590.230.840.650.620.390.620.78-0.490.94-0.70.880.33
0.950.830.880.91-0.610.680.990.89-0.060.850.870.950.590.570.860.830.910.160.850.96-0.080.74-0.640.820.8
0.490.450.690.6-0.120.160.580.560.120.840.470.620.230.570.470.760.650.00.820.470.460.4-0.060.390.54
0.870.970.820.81-0.680.830.870.970.110.820.980.80.840.860.470.820.910.350.820.93-0.290.94-0.740.960.72
0.870.860.870.81-0.610.720.890.910.370.960.870.760.650.830.760.820.90.280.980.86-0.140.8-0.630.840.64
0.880.930.950.83-0.610.760.90.960.00.940.930.90.620.910.650.910.90.220.930.89-0.060.79-0.630.880.89
0.370.420.140.44-0.330.470.240.380.490.160.420.010.390.160.00.350.280.220.180.24-0.520.52-0.40.49-0.08
0.830.840.90.81-0.530.660.880.910.231.00.860.820.620.850.820.820.980.930.180.850.030.76-0.530.810.74
0.960.910.820.86-0.720.820.970.940.130.830.940.870.780.960.470.930.860.890.240.85-0.290.88-0.770.930.7
-0.32-0.350.02-0.060.64-0.62-0.15-0.27-0.470.07-0.340.09-0.49-0.080.46-0.29-0.14-0.06-0.520.03-0.29-0.470.78-0.440.17
0.820.930.660.74-0.720.890.790.930.350.750.950.640.940.740.40.940.80.790.520.760.88-0.47-0.790.970.5
-0.79-0.77-0.54-0.520.88-0.89-0.67-0.74-0.24-0.49-0.78-0.54-0.7-0.64-0.06-0.74-0.63-0.63-0.4-0.53-0.770.78-0.79-0.81-0.43
0.890.980.760.8-0.750.930.860.970.280.80.990.720.880.820.390.960.840.880.490.810.93-0.440.97-0.810.62
0.690.720.870.64-0.420.530.730.74-0.430.760.720.90.330.80.540.720.640.89-0.080.740.70.170.5-0.430.62
Click cells to compare fundamentals

Bloomage Biotechnology Account Relationship Matchups

Bloomage Biotechnology fundamental ratios Accounts

201920202021202220232024 (projected)
Other Liab62.2M56.4M145.9M186.8M214.8M225.6M
Net Tangible Assets4.1B4.5B5.2B5.8B6.6B3.4B
Retained Earnings620.0M1.1B1.7B2.2B2.5B1.4B
Other Assets30.8M69.5M276.0M279.4M321.3M337.4M
Other Stockholder Equity409.0K(1.2M)(11.6K)(23.9M)(21.5M)(20.4M)
Property Plant Equipment492.6M658.3M1.3B2.3B2.7B2.8B
Total Assets5.0B5.7B7.5B8.7B8.5B5.6B
Other Current Liab108.1M173.1M366.8M7.8M5.8M5.5M
Total Current Liabilities365.7M552.9M1.4B1.6B1.2B830.5M
Total Stockholder Equity4.6B5.0B5.7B6.6B6.9B4.6B
Accounts Payable53.3M119.1M243.5M848.3M700.8M735.9M
Cash2.2B1.4B1.8B1.6B1.2B1.4B
Non Current Assets Total1.2B2.1B3.5B4.7B5.3B5.6B
Non Currrent Assets Other54.5M180.6M445.5M558.6M263.6M266.6M
Net Receivables400.9M372.4M396.6M448.4M447.4M391.6M
Non Current Liabilities Total56.4M145.9M400.8M354.7M265.8M191.1M
Inventory314.5M476.8M709.1M1.2B1.1B586.5M
Other Current Assets53.1M650.1M190.4M43.2M40.1M38.0M
Total Liab422.1M698.8M1.8B2.0B1.5B1.0B
Deferred Long Term Liab6.2M18.9M15.6M31.8M36.6M38.5M
Total Current Assets3.8B3.7B4.0B4.0B3.1B3.0B
Intangible Assets385.5M426.7M467.3M475.1M497.0M353.9M
Good Will72.7M74.6M67.2M247.2M251.3M134.9M
Net Invested Capital4.6B5.0B5.9B7.0B7.1B5.2B
Net Working Capital3.4B3.1B2.6B2.4B1.9B2.4B

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

Balance Sheet is a snapshot of the financial position of Bloomage Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Bloomage Biotechnology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bloomage Biotechnology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bloomage currently owns. An asset can also be divided into two categories, current and non-current.